Literature DB >> 26037459

The association between infectious burden and Parkinson's disease: A case-control study.

Xian-Le Bu1, Xin Wang1, Yang Xiang1, Lin-Lin Shen1, Qing-Hua Wang1, Yu-Hui Liu1, Shu-Sheng Jiao1, Ye-Ran Wang1, Hong-Yuan Cao1, Xu Yi1, Cheng-Hui Liu1, Bo Deng1, Xiu-Qing Yao1, Zhi-Qiang Xu1, Hua-Dong Zhou1, Yan-Jiang Wang2.   

Abstract

INTRODUCTION: The etiology of Parkinson's disease (PD) remains unclear. The aim of this study was to examine the association between common pathogenic infections and PD.
METHODS: Antibody titers to common infectious pathogens including cytomegalovirus (CMV), Epstein Barr virus (EBV),herpes simplex virus type-1 (HSV-1), Borrelia burgdorferi (B. burgdorferi), Chlamydophila pneumoniae (C. pneumoniae) and Helicobacter pylori (H. pylori) were measured by ELISA in serum of 131 PD patients and 141 normal controls. Infectious burden (IB) was defined as a composite serologic measure of exposure to these common pathogens.
RESULTS: Seropositivities toward zero-two, three-four and five-six of these pathogens were found in 11%, 74% and 15% of normal controls while in 4%, 61% and 35% of PD patients, respectively. IB, bacterial burden and viral burden were independently associated with PD. Schwab and England (S&E) scores were negatively correlated with IB in patients with PD. Serum α-synuclein protein levels and inflammatory cytokines (interleukin-1β and interleukin-6) in individuals with higher IB were also significantly higher.
CONCLUSIONS: IB consisting of CMV, EBV, HSV-1, B. burgdorferi, C. pneumoniae and H. pylori is associated with PD. This study supports the role of infection in the etiology of PD.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Case-control study; Infections; Parkinson's disease; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 26037459     DOI: 10.1016/j.parkreldis.2015.05.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  36 in total

1.  Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies.

Authors:  Lei Meng; Liang Shen; Hong-Fang Ji
Journal:  J Neurovirol       Date:  2019-01-10       Impact factor: 2.643

2.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

3.  Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study.

Authors:  Shemonti Hasan; Michelle M Mielke; J Eric Ahlskog; James Bower; Pierpaolo Turcano; Rodolfo Savica
Journal:  Mov Disord       Date:  2020-06-01       Impact factor: 10.338

Review 4.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 5.  Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.

Authors:  Elizabeth M Kline; Madelyn C Houser; Mary K Herrick; Philip Seibler; Christine Klein; Andrew West; Malú G Tansey
Journal:  Mov Disord       Date:  2020-12-14       Impact factor: 10.338

6.  Herpesvirus Infections and Risk of Parkinson's Disease.

Authors:  Alejandra Camacho-Soto; Irene Faust; Brad A Racette; David B Clifford; Harvey Checkoway; Susan Searles Nielsen
Journal:  Neurodegener Dis       Date:  2021-01-18       Impact factor: 2.977

Review 7.  Microbial Infections Are a Risk Factor for Neurodegenerative Diseases.

Authors:  Sarah K Lotz; Britanie M Blackhurst; Katie L Reagin; Kristen E Funk
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

8.  Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril.

Authors:  Changyoun Kim; Guohua Lv; Jun Sung Lee; Byung Chul Jung; Masami Masuda-Suzukake; Chul-Suk Hong; Elvira Valera; He-Jin Lee; Seung R Paik; Masato Hasegawa; Eliezer Masliah; David Eliezer; Seung-Jae Lee
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

Review 9.  Neuroinflammation in Parkinson's disease and its potential as therapeutic target.

Authors:  Qinqin Wang; Yingjun Liu; Jiawei Zhou
Journal:  Transl Neurodegener       Date:  2015-10-12       Impact factor: 8.014

Review 10.  Association between Parkinson's Disease and Helicobacter Pylori.

Authors:  Gülşah Çamcı; Sıdıka Oğuz
Journal:  J Clin Neurol       Date:  2016-02-26       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.